# DOLOR THERAPEUTICS, LLC: From Formulation to IND: Optimization of a Dual Cromolyn-Cetirizine Enteric Softgel for Chronic Prostatitis/Chronic Pelvic Pain Syndrome

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | DOLOR THERAPEUTICS, LLC |
| Location | CHICAGO, IL |
| Project | From Formulation to IND: Optimization of a Dual Cromolyn-Cetirizine Enteric Softgel for Chronic Prostatitis/Chronic Pelvic Pain Syndrome |
| Project number | 2R44DK139835-02 |
| Mechanism | R44 |
| Institute | National Institute of Diabetes and Digestive and Kidney Diseases |
| Award | $1,124,999 |
| Awarded | 2026-09-02 |
| Project period | 2024-09-01 to 2028-04-30 |
| UEI | CPVTJJJHGE45 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11407121). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.